Oklahoma recalls
3,509 federal recalls affecting Oklahoma in the last 12 months - 161 Oklahoma-specific plus 3,348 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-09-09FDA-DevicePhilipsClass IINationwidePhilips Ingenuity CT recalled for radiation issue
Philips has identified an unintended radiation issue affecting Philips IQon, iCT, Ingenuity, and Brilliance CT 64 systems that could impact equipment performance. The issue affects specific software versions and product codes distributed in the US and US territories.
- 2026-09-09FDA-DevicePhilipsClass IINationwidePhilips IQon Spectral CT recalled for radiation issue
Philips has identified an unintended radiation issue affecting the IQon Spectral CT and related CT systems (iCT, Ingenuity, and Brilliance CT 64 models). This issue could affect the performance of the equipment. The problem was found in software version 4.7.7.x.
- 2026-09-09FDA-DevicePhilipsClass IINationwidePhilips Brilliance iCT recalled for radiation issue
Philips has identified an unintended radiation issue affecting Philips Brilliance iCT, Brilliance iCT Upgrades, and Brilliance iCT SP CT scanner systems running software version 4.1.10.x. This issue could affect the performance and safety of the equipment.
- 2026-09-09FDA-FoodSavor Fine FoodsClass INationwideSavor Seasonings cheddar seasoning recalled for undeclared milk
Savor Seasonings LLC's bulk Organic Cheddar Type Seasoning tested positive for milk allergen that was not listed on the label. The affected product is packaged in 50-lb bags and distributed in Canada. This poses a serious risk to people with milk allergies.
- 2026-09-09FDA-FoodThe Hampton GrocerClass INationwideThe Hampton Grocer Lacnola granola recalled for Salmonella risk
The Hampton Grocer's Lacnola Small Batch Lactation Granola (8 oz pouches) may be contaminated with Salmonella. Two specific lot codes are affected: HGLC-102125 (expires 21 Oct 2026) and HGLC-021326 (expires 13 Feb 2027).
- 2026-09-09FDA-FoodRon's Home Style FoodsClass IRon's Home Style Foods Salsa Autentica recalled for Salmonella risk
Ron's Home Style Foods recalled Salsa Autentica (Item #DIPSAU0205RFS, 5 lb. containers) because the jalapenos used in the product may be contaminated with Salmonella. The recall affects products with use-by dates between August 27 and September 18, 2026, distributed in Arkansas, Oklahoma, and Texas.
- 2026-09-09FDA-FoodRon's Home Style FoodsClass IRon's Home Style Foods pico de gallo recalled for Salmonella risk
Ron's Home Style Foods pico de gallo was made with jalapenos that may be contaminated with Salmonella. The affected product is a 5 lb container with specific lot codes and use-by dates between August 5 and August 27, 2026. It was distributed in Arkansas, Oklahoma, and Texas.
- 2026-09-09FDA-DrugTevaClass IINationwideTeva trazodone 50 mg recalled for foreign tablets
Teva Pharmaceuticals discovered that some bottles of trazodone 50 mg tablets contain foreign tablets or capsules mixed in with the correct medication. The issue affects one lot (1394026) with an expiration date of February 2028. No injuries have been reported.
- 2026-09-09FDA-DrugSupernusClass IIINationwideSupernus Trokendi XR recalled for dissolution failure
Supernus Pharmaceuticals is recalling one lot of Trokendi XR (topiramate) 50 mg extended-release capsules because the medication did not dissolve as designed. When a medication fails to dissolve properly, the body may not absorb the full dose, potentially reducing its effectiveness.
- 2026-09-09FDA-DrugMylanClass IINationwideMylan Mycophenolate Mofetil injection recalled for dissolution failure
Mylan Pharmaceuticals is recalling specific lots of Mycophenolate Mofetil for injection (500 mg/vial) because the medication failed to meet dissolution specifications—meaning the drug may not dissolve properly in the body. This could affect how well the medicine works. The recall affects two lots distributed nationwide.
- 2026-09-09FDA-DrugAlliesClass IINationwideAllies Group The ONE SPF 50 sunscreen recalled for inadequate protection
Testing by Allies Group found that certain batches of The ONE SPF 50 Invisible Sunscreen Gel may not provide the SPF 50 sun protection stated on the label. The affected product was distributed nationwide in the U.S. No injuries have been reported.
- 2026-09-09FDA-DrugAlliesClass IINationwideAllies Group sunscreen recalled for lower SPF protection than labeled
Testing found that Allies Group THE ONE SPF 50 Invisible Sunscreen Gel may not provide the advertised SPF 50 sun protection. The product was distributed nationwide in the U.S. The affected sunscreen was made in the U.S.A and distributed by Allies Group Pte Ltd.
- 2026-09-09FDA-DrugAlliesClass IINationwideAllies Group THE ONE SPF 50 sunscreen recalled for inadequate protection
Testing found that THE ONE SPF 50 Invisible Sunscreen Gel sachets may not provide the SPF 50 sun protection stated on the label. The affected product was distributed nationwide in the U.S. No injuries have been reported.
- 2026-09-09FDA-DrugAlliesClass IINationwideThe One SPF 50 sunscreen recalled for inadequate protection
Testing by Allies Group Inc. found that The One SPF 50 Invisible Sunscreen Gel may not provide the full SPF 50 sun protection stated on the label. The affected product was distributed nationwide in the U.S. across multiple lot codes with expiration dates through June 2029.
- 2026-09-09FDA-DrugBionpharmaClass IIINationwideBionpharma sleep aid tablets recalled for foreign tablet contamination
Bionpharma Inc. is recalling Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets (10 mg/10 mg, 100-count bottles) because some bottles contain unidentified foreign tablets or capsules mixed in with the correct medication. The affected lot is DMA25006 with an expiration date of 11/30/2028. This issue was discovered during quality control.
- 2026-09-09FDA-DrugBaxterClass IINationwideBaxter Daptomycin injection recalled for manufacturing deviations
Baxter Healthcare is recalling one lot of Daptomycin in 0.9% Sodium Chloride Injection due to deviations from current good manufacturing practice (CGMP) standards during production. The affected lot (NC193856, expiring 04/18/2028) was distributed nationwide, Puerto Rico, and Chile.
- 2026-09-09FDA-DrugBaxterClass IINationwideBaxter Vancomycin Injection recalled for manufacturing deviations
Baxter Healthcare Corporation is recalling one lot of Vancomycin Injection (NDC 0338-3583-01, Lot #NC193894) due to deviations from good manufacturing practices (CGMP). The affected lot was distributed nationwide in the US, Puerto Rico, and Chile.
- 2026-09-09FDA-DrugBaxterClass IINationwideBaxter Vasopressin injection recalled for manufacturing quality issues
Baxter Healthcare Corporation is recalling three lots of Vasopressin injection due to manufacturing process deviations that do not meet FDA quality standards. The affected lots were distributed nationwide, in Puerto Rico, and Chile. No injuries have been reported.
- 2026-09-09FDA-DrugBaxterClass IINationwideBaxter Clindamycin Injection recalled for manufacturing deviations
Baxter Healthcare Corporation is recalling one lot of Clindamycin Injection USP in 5% Dextrose due to deviations from manufacturing quality standards. The affected lot was distributed nationwide, in Puerto Rico, and Chile.
- 2026-09-09FDA-DrugBaxterClass IINationwideBaxter Clindamycin Injection recalled for manufacturing deviations
Baxter Healthcare Corporation is recalling one lot of Clindamycin Injection USP in 5% Dextrose (900 mg/50 mL) due to deviations from current good manufacturing practices (CGMP). The affected lot was distributed nationwide, in Puerto Rico, and Chile. No injuries have been reported.
- 2026-09-09FDA-DrugBaxterClass IINationwideBaxter Clindamycin Phosphate injection recalled for manufacturing deviations
Baxter Healthcare Corporation is recalling a specific lot of Clindamycin Phosphate in 0.9% Sodium Chloride Injection due to deviations from current Good Manufacturing Practice (CGMP) standards during production. The affected lot (NC193689, expiring 10/16/2027) was distributed nationwide, as well as to Puerto Rico and Chile.
- 2026-09-09FDA-DrugBaxterClass IINationwideBaxter Clindamycin Injection recalled for CGMP deviations
Baxter Healthcare has recalled three specific lots of Clindamycin Injection USP (900 mg per 50 mL) due to deviations from Good Manufacturing Practice (CGMP) standards during production. The affected lots were distributed nationwide, Puerto Rico, and Chile. No injuries have been reported.
- 2026-09-09FDA-DrugBaxterClass IINationwideBaxter Nexterone amiodarone recalled for manufacturing deviations
Baxter Healthcare has recalled multiple lots of Nexterone (amiodarone HCI) injection due to deviations from good manufacturing practices (CGMP) during production. The affected lots were distributed nationwide, Puerto Rico, and Chile. No injuries have been reported.
- 2026-09-09FDA-DrugBaxterClass IINationwideBaxter CARDENE IV injection recalled for manufacturing quality issues
Baxter Healthcare has recalled specific lots of CARDENE IV (nicardipine hydrochloride) injection due to deviations from manufacturing quality standards. The affected lots were distributed in the United States, Puerto Rico, and Chile.
- 2026-09-09FDA-DrugBaxterClass IINationwideBaxter Pantoprazole Sodium injection recalled for quality deviations
Baxter Healthcare Corporation is recalling one lot of Pantoprazole Sodium in 0.9% Sodium Chloride Injection due to deviations from current good manufacturing practices (CGMP). The affected lot was distributed in the United States, Puerto Rico, and Chile.
- 2026-09-09FDA-DrugBaxterClass IINationwideBaxter Vasopressin injection recalled for manufacturing deviations
Baxter Healthcare is recalling specific lots of Vasopressin injection due to deviations from manufacturing standards (CGMP). The affected lots may not meet required quality and purity standards. This is a precautionary recall of a medication used in hospitals and clinical settings.
- 2026-09-09FDA-DrugBaxterClass IINationwideBaxter dexmedetomidine injection recalled for manufacturing deviations
Baxter Healthcare Corporation is recalling specific lots of dexmedetomidine hydrochloride injection due to deviations from current good manufacturing practice (CGMP) standards during production. The affected lots were distributed nationwide, in Puerto Rico, and Chile.
- 2026-09-09FDA-DrugBaxterClass IINationwideBaxter famotidine injection recalled for manufacturing deviations
Baxter Healthcare is recalling two lots of famotidine injection (20 mg in 50 mL sodium chloride) due to deviations from manufacturing standards. The affected lots may not meet quality and sterility requirements.
- 2026-09-09FDA-DrugBaxterClass IINationwideBaxter Clindamycin Injection recalled for manufacturing deviations
Baxter Healthcare Corporation is recalling specific lots of Clindamycin Injection USP in 5% Dextrose due to deviations from current Good Manufacturing Practice (CGMP) standards during production. The affected lots are NC193764 (expiration 10/18/2027) and NC195232 (expiration 11/25/2027), distributed nationwide in the US, Puerto Rico, and Chile.
- 2026-09-09FDA-DrugBaxterClass IINationwideBaxter Daptomycin injection recalled for quality deviations
Baxter Healthcare is recalling one lot of Daptomycin in 0.9% Sodium Chloride Injection due to deviations from good manufacturing practices (CGMP) during production. The affected lot (NC188692, expiring 11/22/2027) was distributed nationwide, in Puerto Rico, and Chile. No injuries have been reported.
Get notified about new Oklahoma recalls
Free weekly digest. Add Oklahoma to your profile to filter alerts to your state.
Get the Sunday Brief